Partnership Program to Reduce Cardiovascular Disparities

减少心血管差异的合作伙伴计划

基本信息

  • 批准号:
    7339435
  • 负责人:
  • 金额:
    $ 1.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-09-30 至 2009-08-31
  • 项目状态:
    已结题

项目摘要

Background: Hypertension and diabetes represent major risk factors for cardiovascular disease, placing a disproportionate burden on minorities and African Americans. Evidence suggests that interventions that improve control rates would significantly reduce cardiovascular disparities. Aims: This proposal is based on a collaborative partnership between the Bon Secours Baltimore Health System (BSBHS) and the University of Maryland Baltimore (UMB). The research-specific aims at UMB and BSBHS are complementary and seek to improve provider and patient approaches to treatment of hypertension and diabetes, respectively. UMB also aims to modify physician related barriers to minority enrollment in clinical trials, and BSBHS to improve )atient adherence to treatment plans. Through didactic training, UMB aims to build a sustainable research )rogram at BSBHS; through cultural sensitivity training, BSBHS expects to enhance the disparities program at UMB. Methods: The relative impact of physician and/or patient interventions for controlling hypertension and diabetes is assessed. This is a hypothesis-testing, prospective study, with an experimental 2X2 factorial design; it is a four-arm randomized controlled trial. Outcomes include adherence and improved knowledge/awareness of guidelines (of patients and their physicians), as well as patient clinical and quality of life measures. The study is powered for the proportion of patients who get to goal. We target enrollment of 800 patients (each for hypertension and diabetes), to afford 80% (up to 90%) power and allow for 25% attrition. We will use logistic regression for the probability of reaching goal, multiple linear regression for relative changes in mmHg (hypertension) and HbAlc (diabetes), and survival analysis to model time to reach goal. We will also measure improved adherence of diabetes patients as a result of BSBHS actively identifying access barriers; and changes in the willingness of patients to enroll in clinical trials as a result of physician-targeted education. Discussion: We seek to demonstrate a best practice model, based on a collaborative partnership, and build a self-sustained research program at BSBHS and an enhanced cardiovascular disparities program at UMB. Community entities will have full access to resources at both institutions, which in turn will have access to invaluable input and support from community groups. We strongly expect improved outcomes/awareness of cardiovascular health among minority patients serviced by both BSBHS and UMB.
背景:高血压和糖尿病是心血管疾病的主要危险因素 少数民族和非裔美国人负担不成比例的负担。有证据表明干预措施 提高控制率将大大降低心血管差异。目的:该提议基于 Bon Secours巴尔的摩卫生系统(BSBHS)与大学之间的合作伙伴关系 马里兰州巴尔的摩(UMB)。针对UMB和BSBH的研究特定目标是互补的,并寻求 分别改善提供者和患者方法分别治疗高血压和糖尿病。 UMB 还旨在修改医师在临床试验中与少数群体入学的障碍,并改善BSBHS )遵守治疗计划。通过教学培训,UMB旨在建立可持续的研究 )在BSBHS的ROGRAM;通过文化敏感性培训,BSBHS希望增强差异计划 在UMB。方法:医师和/或患者干预对控制高血压的相对影响 评估糖尿病。这是一项假设测试,前瞻性研究,具有实验2x2阶乘 设计;这是一项四臂随机对照试验。结果包括依从性和改善 (患者及其医生)的知识/意识以及患者的临床和质量 生活措施。该研究适用于目标患者的比例。我们针对的是 800名患者(每个患有高血压和糖尿病),可提供80%(高达90%)的功率,允许25% 损耗。我们将使用逻辑回归来达到目标​​的概率,多个线性回归 MMHG(高血压)和HBALC(糖尿病)的相对变化以及生存分析以建模时间到达 目标。我们还将由于BSBH的积极衡量糖尿病患者的依从性提高 确定访问障碍;以及由于患者愿意参加临床试验的意愿而变化 针对医师的教育。讨论:我们试图根据一个 合作伙伴关系,并在BSBHS建立自我维持的研究计划 UMB的心血管差异计划。社区实体将在两者中都可以完全访问资源 机构又可以访问社区群体的宝贵意见和支持。我们 强烈期望在服务的少数族裔患者中提高结果/心血管健康的意识 BSBHS和UMB均为。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

ELIJAH SAUNDERS的其他基金

BALTIMORE PARTNERSHIP PROGRAM TO REDUCE CARDIOVASCULAR DISPARITIES
减少心血管差异的巴尔的摩合作伙伴计划
  • 批准号:
    7608148
    7608148
  • 财政年份:
    2007
  • 资助金额:
    $ 1.71万
    $ 1.71万
  • 项目类别:
BALTIMORE PARTNERSHIP PROGRAM TO REDUCE CARDIOVASCULAR DISPARITIES
减少心血管差异的巴尔的摩合作伙伴计划
  • 批准号:
    7376967
    7376967
  • 财政年份:
    2006
  • 资助金额:
    $ 1.71万
    $ 1.71万
  • 项目类别:
Partnership Program to Reduce Cardiovascular Disparities
减少心血管差异的合作伙伴计划
  • 批准号:
    7339704
    7339704
  • 财政年份:
    2004
  • 资助金额:
    $ 1.71万
    $ 1.71万
  • 项目类别:
Partnership Program to Reduce Cardiovascular Disparities
减少心血管差异的合作伙伴计划
  • 批准号:
    6951612
    6951612
  • 财政年份:
    2004
  • 资助金额:
    $ 1.71万
    $ 1.71万
  • 项目类别:
Partnership Program to Reduce Cardiovascular Disparities
减少心血管差异的合作伙伴计划
  • 批准号:
    6861331
    6861331
  • 财政年份:
    2004
  • 资助金额:
    $ 1.71万
    $ 1.71万
  • 项目类别:
Partnership Program to Reduce Cardiovascular Disparities
减少心血管差异的合作伙伴计划
  • 批准号:
    7496026
    7496026
  • 财政年份:
    2004
  • 资助金额:
    $ 1.71万
    $ 1.71万
  • 项目类别:
Partnership Program to Reduce Cardiovascular Disparities
减少心血管差异的合作伙伴计划
  • 批准号:
    7087602
    7087602
  • 财政年份:
    2004
  • 资助金额:
    $ 1.71万
    $ 1.71万
  • 项目类别:
Partnership Program to Reduce Cardiovascular Disparities
减少心血管差异的合作伙伴计划
  • 批准号:
    7340816
    7340816
  • 财政年份:
    2004
  • 资助金额:
    $ 1.71万
    $ 1.71万
  • 项目类别:
Partnership Program to Reduce Cardiovascular Disparities
减少心血管差异的合作伙伴计划
  • 批准号:
    7078039
    7078039
  • 财政年份:
    2004
  • 资助金额:
    $ 1.71万
    $ 1.71万
  • 项目类别:
Partnership Program to Reduce Cardiovascular Disparities
减少心血管差异的合作伙伴计划
  • 批准号:
    7280916
    7280916
  • 财政年份:
    2004
  • 资助金额:
    $ 1.71万
    $ 1.71万
  • 项目类别:

相似国自然基金

阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
  • 批准号:
    82302281
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
  • 批准号:
    82300697
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
  • 批准号:
    22304039
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
  • 批准号:
    82300173
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
  • 批准号:
    82360957
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
  • 批准号:
    10822202
    10822202
  • 财政年份:
    2024
  • 资助金额:
    $ 1.71万
    $ 1.71万
  • 项目类别:
Determining medications associated with drug-induced pancreatic injury through novel pharmacoepidemiology techniques that assess causation
通过评估因果关系的新型药物流行病学技术确定与药物引起的胰腺损伤相关的药物
  • 批准号:
    10638247
    10638247
  • 财政年份:
    2023
  • 资助金额:
    $ 1.71万
    $ 1.71万
  • 项目类别:
TIER-PALLIATIVE CARE: A population-based care delivery model to match evolving patient needs and palliative care services for community-based patients with heart failure or cancer
分级姑息治疗:基于人群的护理提供模式,以满足不断变化的患者需求,并为社区心力衰竭或癌症患者提供姑息治疗服务
  • 批准号:
    10880994
    10880994
  • 财政年份:
    2023
  • 资助金额:
    $ 1.71万
    $ 1.71万
  • 项目类别:
Identification of gene variants mediating the behavioral and physiological response to THC
鉴定介导 THC 行为和生理反应的基因变异
  • 批准号:
    10660808
    10660808
  • 财政年份:
    2023
  • 资助金额:
    $ 1.71万
    $ 1.71万
  • 项目类别:
Kinetochore Assembly and Regulation
着丝粒组装和调控
  • 批准号:
    10717202
    10717202
  • 财政年份:
    2023
  • 资助金额:
    $ 1.71万
    $ 1.71万
  • 项目类别: